Screener
Nuvation Bio NUVB Gross Profit
Discontinued — last reported Q3 '25
Gross Profit at other companies
Other financials
Where this comes from
Calculated from Nuvation Bio’s reported figures.
The source filing: Nuvation Bio’s 10-Q, filed November 3, 2025.
- Filed
- Nov 3, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001193125-25-262605
| Line item | For the Three Months Ended September 30, 2025 | For the Three Months Ended September 30, 2024 | For the Nine Months Ended September 30, 2025 | For the Nine Months Ended September 30, 2024 |
|---|---|---|---|---|
| Collaboration and license agreements revenue | 5,397 | 727 | 12,076 | 2,162 |
| Total revenues | 13,120 | 727 | 21,037 | 2,162 |
| Cost of revenue | 3,349 | 1,515 | 8,019 | 2,862 |
| Gross profit (deficit) | 9,771 | (788) | 13,018 | (700) |
| Operating expenses: | ||||
| Research and development | 28,846 | 27,731 | 80,809 | 69,820 |
| Acquired in-process research and development | — | — | — | 425,070 |
| Selling, general and administrative | 37,359 | 19,582 | 111,236 | 43,095 |
Item 1. Financial Statements.
FAQ
- What is Nuvation Bio's gross profit?
- Nuvation Bio (NUVB) reported gross profit of $9.77M in Q3 2025.
- How has Nuvation Bio's gross profit changed year-over-year?
- Nuvation Bio's gross profit increased by 1340.0% year-over-year, from -$788K to $9.77M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about Nuvation Bio's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude